Chromadex Corp

NASDAQ:CDXCUnited States

Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Contact Information

Headquarters

10900 Wilshire Blvd, Suite 600LOS ANGELES, CA, United States 90024

Phone

310-388-6706

Fax

302-421-5753

Executives

Chairman of the Board

Frank Jaksch

Chief Executive Officer, Director

Robert Fried

Chief Financial Officer, Principal Accounting Officer

Ozan Pamir

Senior Vice President, General Counsel

Carlos Lopez

Lead Independent Director

Steven Rubin